Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong

被引：7

作者：

Chan, Denise Pui Chung ^{[1
]}

Wong, Ngai Sze ^{[1
]}

Wong, Bonnie C. K. ^{[2
]}

Chan, Jacky M. C. ^{[3
]}

Lee, Shui Shan ^{[1
]}

机构：

[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[2] Dept Hlth, Hong Kong, Peoples R China

[3] Princess Margaret Hosp, Hong Kong, Peoples R China

来源：

EMERGING INFECTIOUS DISEASES | 2022年 / 28卷 / 10期

关键词：

PEOPLE;

D O I：

10.3201/eid2810.220691

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In a cohort of persons living with HIV in Hong Kong, sur-rogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.

引用

页码：2130 / 2132

页数：3

共 9 条

[1] More evidence for worse COVID-19 outcomes in people with HIV [J].

Boffito, Marta ;

Waters, Laura .

LANCET HIV, 2021, 8 (11) :E661-E662

[2] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination [J].

Cheng, Samuel M. S. ;

Mok, Chris Ka Pun ;

Leung, Yonna W. Y. ;

Ng, Susanna S. ;

Chan, Karl C. K. ;

Ko, Fanny W. ;

Chen, Chunke ;

Yiu, Karen ;

Lam, Bosco H. S. ;

Lau, Eric H. Y. ;

Chan, Ken K. P. ;

Luk, Leo L. H. ;

Li, John K. C. ;

Tsang, Leo C. H. ;

Poon, Leo L. M. ;

Hui, David S. C. ;

Peiris, Malik .

NATURE MEDICINE, 2022, 28 (03) :486-+

[3] Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study [J].

Feng, Yanmeng ;

Zhang, Yifan ;

He, Zhangyufan ;

Huang, Haojie ;

Tian, Xiangxiang ;

Wang, Gang ;

Chen, Daihong ;

Ren, Yanqin ;

Jia, Liqiu ;

Wang, Wanhai ;

Wu, Jing ;

Shao, Lingyun ;

Zhang, Wenhong ;

Tang, Heng ;

Wan, Yanmin .

ECLINICALMEDICINE, 2022, 43

[4] A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study at 18 Serial Time Points Over 368 Days [J].

Liang, Xian-Ming ;

Xu, Qiu-Yan ;

Jia, Zhi-Juan ;

Wu, Meng-Juan ;

Liu, Yan-Yun ;

Lin, Li-Rong ;

Liu, Li-Li ;

Yang, Tian-Ci .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[5] CHINA'S COVID VACCINES HAVE BEEN CRUCIAL - NOW IMMUNITY IS WANING [J].

Mallapaty, Smriti .

NATURE, 2021, 598 (7881) :398-399

[6] Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study [J].

Netto, Lucas C. ;

Ibrahim, Karim Y. ;

Picone, Camila M. ;

Alves, Ana Paula P. S. ;

Aniceto, Eliane, V ;

Santiago, Mariana R. ;

Parmejani, Patricia S. S. ;

Aikawa, Nadia E. ;

Medeiros-Ribeiro, Ana C. ;

Pasoto, Sandra G. ;

Yuki, Emily F. N. ;

Saad, Carla G. S. ;

Pedrosa, Tatiana ;

Lara, Amanda N. ;

Ceneviva, Carina ;

Bonfa, Eloisa ;

Kallas, Esper G. ;

Avelino-Silva, Vivian, I .

LANCET HIV, 2022, 9 (05) :E323-E331

[7] A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction [J].

Tan, Chee Wah ;

Chia, Wan Ni ;

Qin, Xijian ;

Liu, Pei ;

Chen, Mark I-C ;

Tiu, Charles ;

Hu, Zhiliang ;

Chen, Vivian Chih-Wei ;

Young, Barnaby E. ;

Sia, Wan Rong ;

Tan, Yee-Joo ;

Foo, Randy ;

Yi, Yongxiang ;

Lye, David C. ;

Anderson, Danielle E. ;

Wang, Lin-Fa .

NATURE BIOTECHNOLOGY, 2020, 38 (09) :1073-+

[8] Surrogate neutralization responses following severe acute respiratory syndrome coronavirus 2 vaccination in people with HIV: comparison between inactivated and mRNA vaccine [J].

Wong, Ngai Sze ;

Wong, Bonnie C. K. ;

Chan, Jacky M. C. ;

Wong, Ka Hing ;

Tsang, Owen T. Y. ;

Mok, Chris K. P. ;

Hui, David S. C. ;

Lee, Shui Shan ;

Chan, Denise P. C. .

AIDS, 2022, 36 (09) :1255-1264

[9] Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials [J].

Zeng, Gang ;

Wu, Qianhui ;

Pan, Hongxing ;

Li, Minjie ;

Yang, Juan ;

Wang, Lin ;

Wu, Zhiwei ;

Jiang, Deyu ;

Deng, Xiaowei ;

Chu, Kai ;

Zheng, Wen ;

Wang, Lei ;

Lu, Wanying ;

Han, Bihua ;

Zhao, Yuliang ;

Zhu, Fengcai ;

Yu, Hongjie ;

Yin, Weidong .

LANCET INFECTIOUS DISEASES, 2022, 22 (04) :483-495

← 1 →